Two more assets are being repositioned for life science uses.
Funds managed by Blackstone Real Estate Partners are buying two adjacent office towers in Boston from CIM Group and Nordblom Company.
The towers, located at 1000 Washington St. and 321 Harrison Ave., will be operated by BioMed Realty. The Boston towers' large, flexible floorplates, floor-to-ceiling windows and energy-efficient mechanical systems will allow BioMed to convert them to life science uses. The towers' amenities include outdoor areas and a rooftop terrace, a state-of-the-art tenant fitness center, outdoor café, bike storage, covered parking, and front desk services in a shared two-story lobby.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Leslie Shaver
Les Shaver has been covering commercial and residential real estate for almost 20 years. His work has appeared in Multifamily Executive, Builder, units, Arlington Magazine in addition to GlobeSt.com and Real Estate Forum.
